Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010

Thorax

Volumn 65, Issue SUPPL. 2, 2010, Pages

  Roberts, Mark E ^a   Neville, Edmund ^b   Berrisford, Richard G ^c   Antunes, George ^d   Ali, Nabeel J ^a  

^a KING S MILL HOSPITAL   (United Kingdom)

^b PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^c ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^d SOUTH TEES HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; FIBRINOLYTIC AGENT; SCLEROSING AGENT; TALC; TETRACYCLINE;

ANALGESIA; ARTICLE; BRITISH THORACIC SOCIETY PLEURAL DISEASE GUIDELINE 2010; CLINICAL ASSESSMENT; HUMAN; INDWELLING CATHETER; MALIGNANT PLEURAL EFFUSION; MALIGNANT TRANSFORMATION; PLEURA EFFUSION; PLEURECTOMY; PLEURODESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; THORACOSCOPY; THORAX DRAINAGE; ALGORITHM; METHODOLOGY; SUCTION; TUMOR SEEDING;

ALGORITHMS; CATHETERS, INDWELLING; FIBRINOLYTIC AGENTS; HUMANS; NEOPLASM SEEDING; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; SCLEROSING SOLUTIONS; SUCTION; THORACOSCOPY;

EID: 77956024760     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.136994     Document Type: Article

References (154)

1. Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 1977;63:695-702. (3).
2. Abbruzzese JL, Abbruzzese MC, Hess KR, et al. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994;12:1272-80. (2+).
3. van de Molengraft FJ, Vooijs GP. Survival of patients with malignancy-associated effusions. Acta Cytol 1989;33:911-16. (2+).
4. Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol 1987;31:85-97. (2+).
5. Bonnefoi H, Smith IE. How should cancer presenting as a malignant pleural effusion be managed? Br J Cancer 1996;74:832-5. (2-).
6. Kolschmann S, Ballin A, Gillissen A. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions. Chest 2005;128:1431-5. (2-).
7. Raju RN, Kardinal CG. Pleural effusion in breast carcinoma: analysis of 122 cases. Cancer 1981;48:2524-7. (3).
8. Fentiman IS, Millis R, Sexton S, et al. Pleural effusion in breast cancer: a review of 105 cases. Cancer 1981;47:2087-92. (3).
9. Banerjee AK, Willetts I, Robertson JF, et al. Pleural effusion in breast cancer: a review of the Nottingham experience. Eur J Surg Oncol 1994;20:33-6. (3).
10. Dieterich M, Goodman SN, Rojas-Corona RR, et al. Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients. Acta Cytol 1994;38:945-52. (3).
11. DiBonito L, Falconieri G, Colautti I, et al. The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol 1992;36:329-32. (2+).
12. Hsu C. Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients. Diagn Cytopathol 1987;3:8-12. (2-).
13. Johnston WW. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 1985;56:905-9. (3).
14. Salyer WR, Eggleston JC, Erozan YS. Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest 1975;67:536-9. (3).
15. Heffner JE, Heffner JN, Brown LK. Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions. Chest 2003;123:1887-94. (1-).
16. Rodriguez-Panadero F, Lopez Mejias J. Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis. Am Rev Respir Dis 1989;139:663-7. (2+).
17. Gottehrer A, Taryle DA, Reed CE, et al. Pleural fluid analysis in malignant mesothelioma. Prognostic implications. Chest 1991;100:1003-6. (3).
18. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000;117:73-8. (2+).
19. Judson M, Sahn S. Pulmonary physiologic abnormalities caused by pleural disease. Semin Respir Crit Care Med 1995;16:346-53. (4).
20. Maher GG, Berger HW. Massive pleural effusion: malignant and nonmalignant causes in 46 patients. Am Rev Respir Dis 1972;105:458-60. (3).
21. Parulekar W, Di Primio G, Matzinger F, et al. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions. Chest 2001;120:19-25. (2+).
22. Clementsen P, Evald T, Grode G, et al. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med 1998;92:593-6. (1+).
23. Caglayan B, Torun E, Turan D, et al. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube. Ann Surg Oncol 2008;15:2594-9. (1+).
24. Seaton KG, Patz EF Jr, Goodman PC. Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. JR 1995;164:589-91. (2+).
25. Morrison MC, Mueller PR, Lee MJ, et al. Sclerotherapy of malignant pleural effusion through sonographically placed small-bore catheters. AJR 1992;158:41-3. (2+).
26. Parker LA, Charnock GC, Delany DJ. Small bore catheter drainage and sclerotherapy for malignant pleural effusions. Cancer 1989;64:1218-21. (3).
27. Feller-Kopman D, Walkey A, Berkowitz D, et al. The relationship of pleural pressure to symptom development during therapeutic thoracentesis. Chest 2006;129:1556-60. (2-).
28. Sorensen PG, Svendsen TL, Enk B. Treatment of malignant pleural effusion with drainage, with and without instillation of talc. Eur J Respir Dis 1984;65:131-5. (1-). (Pubitemid 14188709)
29. Zaloznik AJ, Oswald SG, Langin M. Intrapleural tetracycline in malignant pleural effusions. A randomized study. Cancer 1983;51:752-5. (1-).
30. Leverenz A, Heckmayr M, Tischer-Neuhauss R, et al. Intrapleural palliative treatment of malignant pleural effusions with talcum versus placebo (pleural tube alone) [abstract]. Lung Cancer 2000;29A274. (1-).
31. Groth G, Gatzemeier U, Haussingen K, et al. Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann Oncol 1991;2:213-15. (1+).
32. O'Neill W, Spurr C, Moss H, et al. A prospective study of chest tube drainage and tetracycline sclerosis versus chest tube drainage alone in the treatment of malignant pleural effusions [abstract]. Proc Annu Meet Am Assoc Cancer Res 1980;21:349. (3).
33. Lambert CJ, Shah HH, Urshel HC Jr, et al. The treatment of malignant pleural effusions by closed trocar tube drainage. Ann Thorac Surg 1967;3:1-5. (2-).
34. Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusions. Cancer 1974;33:916-22. (3).
35. Izbicki R, Weyhing BT 3rd, Baker L, et al. Pleural effusion in cancer patients. A prospective randomized study of pleural drainage with the addition of radioactive phosphorous to the pleural space vs. pleural drainage alone. Cancer 1975;36:1511-18. (1e).
36. Boland GW, Gazelle GS, Girard MJ, et al. Asymptomatic hydropneumothorax after therapeutic thoracentesis for malignant pleural effusions. AJR 1998;170:943-6. (2-).
37. Antony VB. Pathogenesis of malignant pleural effusions and talc pleurodesis. Pneumologie 1999;53:493-8. (2+).
38. Antony VB, Rothfuss KJ, Godbey SW, et al. Mechanism of tetracyclinehydrochloride- induced pleurodesis. Tetracycline-hydrochloride- stimulated mesothelial cells produce a growth-factor-like activity for fibroblasts. Am Rev Respir Dis 1992;146:1009-13. (2-).
39. Antony VB, Nasreen N, Mohammed KA, et al. Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis. Chest 2004;126:1522-8. (2-)
40. Rodriguez-Panadero F, Segado A, Martin Juan J, et al. Failure of talc pleurodesis is associated with increased pleural fibrinolysis. Am J Respir Crit Care Med 1995;151(3 Pt 1):785-90. (2+).
41. Xie C, Teixeira LR, McGovern JP, et al. Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am J Respir Crit Care Med 1998; 157(5 Pt 1):1441-4. (2+).
42. Haddad FJ, Younes RN, Gross JL, et al. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial. World J Surg 2004;28:749-54. (1-).
43. Hunt I, Teh E, Southon R, et al. Using non-steroidal anti-inflammatory drugs (NSAIDs) following pleurodesis. Interact Cardiovasc Thorac Surg 2007;6:102-4. (4).
44. Hausheer FH, Yarbro JW. Diagnosis and treatment of malignant pleural effusion. Semin Oncol 1985;12:54-75. (2-).
45. Owen S, Gould D. Underwater seal chest drains: the patient's experience. J Clin Nurs 1997;6:215-25. (2-).
46. Goff BA, Mueller PR, Muntz HG, et al. Small chest-tube drainage followed by bleomycin sclerosis for malignant pleural effusions. Obstet Gynecol 1993;81:993-6. (3).
47. Chen YM, Shih JF, Yang KY, et al. Usefulness of pig-tail catheter for palliative drainage of malignant pleural effusions in cancer patients. Support Care Cancer 2000;8:423-6. (2-).
48. Patz EF Jr, McAdams HP, Erasmus JJ, et al. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with smallbore catheter drainage. Chest 1998;113:1305-11. (1-).
49. Patz EF Jr, McAdams HP, Goodman PC, et al. Ambulatory sclerotherapy for malignant pleural effusions. Radiology 1996;199:133-5. (2-).
50. Tarver RD, Broderick LS, Conces DJ Jr. Reexpansion pulmonary edema. J Thorac Imaging 1996;11:198-209. (4).
51. Mahfood S, Hix WR, Aaron BL, et al. Reexpansion pulmonary edema. Ann Thorac Surg 1988;45:340-5. (3).
52. Nakamura H, Ishizaka A, Sawafuji M, et al. Elevated levels of interleukin-8 and leukotriene B4 in pulmonary edema fluid of a patient with reexpansion pulmonary edema. Am J Respir Crit Care Med 1994;149(4 Pt 1):1037-40. (3).
53. Trachiotis GD, Vricella LA, Aaron BL, et al. As originally published in 1988: Reexpansion pulmonary edema. Updated in 1997. Ann Thorac Surg 1997;63:1206-7. (4).
54. Adler RH, Sayek I. Treatment of malignant pleural effusion: a method using tube thoracostomy and talc. Ann Thorac Surg 1976;22:8-15. (3).
55. Villanueva AG, Gray AW Jr, Shahian DM, et al. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994;49:23-5. (1+).
56. Kennedy L, Rusch VW, Strange C, et al. Pleurodesis using talc slurry. Chest 1994;106:342-6. (2-).
57. Robinson LA, Fleming WH, Galbraith TA. Intrapleural doxycycline control of malignant pleural effusions. Ann Thorac Surg 1993;55:1115-22. (2-).
58. Goodman A, Davies CWH. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer 2006;54:51-5. (1-).
59. Pulsiripunya C, Youngchaiyud P, Pushpakom R, et al. The efficacy of doxycycline as a pleural sclerosing agent in malignant pleural effusion: a prospective study. Respirology 1996;1:69-72. (2-).
60. Wooten SA, Barbarash RA, Strange C, et al. Systemic absorption of tetracycline and lidocaine following intrapleural instillation. Chest 1988;94:960-3. (2-).
61. Sherman S, Grady KJ, Seidman JC. Clinical experience with tetracycline pleurodesis of malignant pleural effusions. South Med J 1987;80:716-19. (2-).
62. Whitwam J, C W. Sedation and sedoanalgesia. In: Whitwam J, editor. Day-case anaesthesia and sedation. London: Blackwell Scientific Publications; 1994:262-74. (4).
63. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004;(1):002916. (1++).
64. Tan C, Sedrakyan A, Browne J, et al. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg 2006;29:829-38. (1+).
65. Heffner JE, Unruh LC. Tetracycline pleurodesis. Adios, farewell, adieu. Chest 1992;101:5-7. (4).
66. Bethune N. Pleural poudrage: new technique for deliberate production of pleural adhesions as preliminary to lobectomy. J Thorac Cardiovasc Surg 1935;4:251-61. (3).
67. Webb WR, Ozmen V, Moulder PV, et al. Iodized talc pleurodesis for the treatment of pleural effusions. J Thorac Cardiovasc Surg 1992;103:881-6. (2-).
68. Yim AP, Chan AT, Lee TW, et al. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996;62:1655-8. (1-).
69. Marom EM, Patz EF Jr, Erasmus JJ, et al. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 1999;210:277-81. (2+).
70. Thompson RL, Yau JC, Donnelly RF, et al. Pleurodesis with iodized talc for malignant effusions using pigtail catheters. Ann Pharmacother 1998;32:739-42. (3).
71. Lynch TJ Jr. Optimal therapy of malignant pleural effusions: Report of a randomized trial of bleomycin, tetracycline, and talc and a meta-analysis. Int J Oncol 1996;8:183-90. (1-).
72. Zimmer PW, Hill M, Casey K, et al. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 1997;112:430-4. (1+).
73. Manes N, Rodriguez-Panadero F, Bravo J, et al. Talc pleurodesis. Prospective and randomized study clinical follow up [abstract]. Chest 2000;118:131S. (1-)
74. . Dresler CM, Olak J, Herndon JE 2nd, et al. Phase 3 intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005;127:909-15. (1-).
75. Stefani A, Natali P, Casali C, et al. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Eur J Cardiothorac Surg 2006;30:827-32. (2-).
76. Diacon AH, Wyser C, Bolliger CT, et al. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions. Am J Respir Crit Care Med 2000;162(4 Pt 1):1445-9. (1+).
77. Kuzdzal J, Sladek K, Wasowski D, et al. Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial. Med Sci Monitor 2003;9:PI54-9. (1-).
78. Fentiman IS, Rubens RD, Hayward JL. A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Cancer Clin Oncol 1986;22:1079-81. (1L)
79. Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology 2001;6:181-5. (2-).
80. Rinaldo JE, Owens GR, Rogers RM. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg 1983;85:523-6. (3).
81. Bouchama A, Chastre J, Gaudichet A, et al. Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest 1984;86:795-7. (3).
82. Rehse DH, Aye RW, Florence MG. Respiratory failure following talc pleurodesis. Am J Surg 1999;177:437-40. (2-).
83. Campos JRM, Werebe EC, Vargas FS, et al. Respiratory failure due to insufflated talc. Lancet 1997;349:251-2. (3).
84. Nandi P. Recurrent spontaneous pneumothorax; an effective method of talc poudrage. Chest 1980;77:493-5. (4).
85. Ferrer J, Villarino MA, Tura JM, et al. Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest 2001;119:1901-5. (2++).
86. Kuzniar T, Mutlu GM. Post-talc pleurodesis acute lung injury: case report and review of literature. Adv Clin Exp Med 2004;13:367-70. (3).
87. Bondoc AY, Bach PB, Sklarin NT, et al. Arterial desaturation syndrome following pleurodesis with talc slurry: incidence, clinical features, and outcome. Cancer Invest 2003;21:848-54. (2-).
88. Maskell NA, Lee YC, Gleeson FV, et al. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 2004;170:377-82. (1+).
89. Janssen JP, Collier G, Astoul P, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007;369:1535-9. (2++).
90. Werebe EC, Pazetti R, Milanez de Campos JR, et al. Systemic distribution of talc after intrapleural administration in rats. Chest 1999;115:190-3. (2+).
91. Fraticelli A, Robaglia-Schlupp A, Riera H, et al. Distribution of calibrated talc after intrapleural administration: an experimental study in rats. Chest 2002;122:1737-41. (2+).
92. Ferrer J, Montes JF, Villarino MA, et al. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest 2002;122:1018-27. (2+).
93. Alberts DS, Chen HS, Mayersohn M, et al. Bleomycin pharmacokinetics in man. 2. Intracavitary administration. Cancer Chemother Pharmacol 1979;2:127-32. (3).
94. Bitran JD, Brown C, Desser RK, et al. Intracavitary bleomycin for the control of malignant effusions. J Surg Oncol 1981;16:273-7. (3).
95. Emad A, Rezaian GR. Treatment of malignant pleural effusions with a combination of bleomycin and tetracycline. A comparison of bleomycin or tetracycline alone versus a combination of bleomycin and tetracycline. Cancer 1996;78:2498-501. (1-).
96. Hamed H, Fentiman IS, Chaudary MA, et al. Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast. Br J Surg 1989;76:1266-7. (1+).
97. Hartman DL, Gaither JM, Kesler KA, et al. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg 1993;105:743-8. (2-).
98. Kessinger A, Wigton RS. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study. J Surg Oncol 1987;36:81-3. (1-).
99. Martinez-Moragon E, Aparicio J, Rogado MC, et al. Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin. Eur Respir J 1997;10:2380-3. (1+).
100. Noppen M, Degreve J, Mignolet M, et al. A prospective, randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleural effusions. Acta Clin Belg 1997;52:258-62. (1+).
101. Ong KC, Indumathi V, Raghuram J, et al. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions. Respirology 2000;5:99-103. (1-).
102. Ruckdeschel JC, Moores D, Lee JY, et al. Intrapleural therapy for malignant pleural effusions. a randomized comparison of bleomycin and tetracycline [erratum appears in Chest 1993;103:1640]. Chest 1991;100:1528-35. (1++).
103. Hsu WH, Chiang CD, Chen CY, et al. Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion. Jpn J Clin Oncol 1998;28:187-91. (3).
104. Kilic D, Akay H, Kavukcu S, et al. Management of recurrent malignant pleural effusion with chemical pleurodesis. Surg Today 2005;35:634-8. (3).
105. Lorch DG, Gordon L, Wooten S, et al. Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis. Chest 1988;93:527-9. (3).
106. Dryzer SR, Allen ML, Strange C, et al. A comparison of rotation and nonrotation in tetracycline pleurodesis. Chest 1993;104:1763-6. (1-).
107. Mager HJ, Maesen B, Verzijlbergen F, et al. Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis. Lung Cancer 2002;36:77-81. (1+).
108. Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J 1997;10:1907-13. (4).
109. Lynch TJ Jr. Management of malignant pleural effusions. Chest 1993; 103(4 Suppl):385-9S. (4).
110. Jones FL Jr. Subcutaneous implantation of cancer: a rare complication of pleural biopsy. Chest 1970;57:189-90. (3).
111. Berger RL, Dargan EL, Huang BL. Dissemination of cancer cells by needle biopsy of the lung. J Thorac Cardiovasc Surg 1972;63:430-2. (3).
112. Kumar UN, Varkey B. Case report: subcutaneous metastasis. Rare complication of drainage of malignant pleural fluid. Postgrad Med 1976;60:253-5. (3).
113. Chen TP, Liu HP, Lu HI, et al. Incidence of incisional recurrence after thoracoscopy. Surg Endosc 2004;18:540-2. (2-).
114. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995;108:754-8. (1+).
115. O'Rourke N, Garcia JC, Paul J, et al. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol 2007;84:18-22. (1+).
116. Bydder S, Phillips M, Joseph DJ, et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer 2004;91:9-10. (1+).
117. Low EM, Khoury GG, Matthews AW, et al. Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy. Clin Oncol 1995;7:317-18. (3).
118. Agarwal PP, Seely JM, Matzinger FR, et al. Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy. Radiology 2006;241:589-94. (2-).
119. West SD, Foord T, Davies RJ. Needle-track metastases and prophylactic radiotherapy for mesothelioma. Respir Med 2006;100:1037-40. (2-).
120. Davies CW, Traill ZC, Gleeson FV, et al. Intrapleural streptokinase in the management of malignant multiloculated pleural effusions. Chest 1999;115:729-33. (3).
121. Gilkeson RC, Silverman P, Haaga JR. Using urokinase to treat malignant pleural effusions. AJR 1999;173:781-3. (3).
122. Hsu L-H, Soong TC, Feng A-C, et al. Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients. J Thorac Oncol 2006;1:460-7. (2-).
123. Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J Clin Invest 1949;28:173-90. (3).
124. Godley PJ, Bell RC. Major hemorrhage following administration of intrapleural streptokinase. Chest 1984;86:486-7. (3).
125. Loddenkemper R. Thoracoscopy: state of the art. Eur Respir J 1998;11:213-21. (4).
126. Harris RJ, Kavuru MS, Rice TW, et al. The diagnostic and therapeutic utility of thoracoscopy. A review. Chest 1995;108:828-41. (4).
127. Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med 1991;114:271-6. (3).
128. Danby CA, Adebonojo SA, Moritz DM. Video-assisted talc pleurodesis for malignant pleural effusions utilizing local anesthesia and I.V. sedation. Chest 1998;113:739-42. (3).
129. Arapis K, Caliandro R, Stern JB, et al. Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients. Surg Endosc 2006;20:919-23. (2+).
130. Canto A, Blasco E, Casillas M, et al. Thoracoscopy in the diagnosis of pleural effusion. Thorax 1977;32:550-4. (3).
131. Ferrer J, Roldan J, Teixidor J, et al. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Chest 2005;127:1017-22. (2+).
132. Aelony Y, King RR, Boutin C. Thoracoscopic talc poudrage in malignant pleural effusions: effective pleurodesis despite low pleural pH. Chest 1998;113:1007-12. (2-).
133. Debeljak A, Kecelj P, Triller N, et al. Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions. J BUON 2006;11:463-7. (2-).
134. Foroulis CN, Kotoulas C, Konstantinou M, et al. The management of malignant pleural effusions: talc pleurodesis versus bleomycin pleurodesis. J BUON 2001;6:397-400. (3).
135. Harley HR. Malignant pleural effusions and their treatment by intercostal talc pleurodesis. Br J Dis Chest 1979;73:173-7. (3).
136. Jones GR. Treatment of recurrent malignant pleural effusion by iodized talc pleurodesis. Thorax 1969;24:69-73. (3).
137. Viallat JR, Rey F, Astoul P, et al. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest 1996;110:1387-93. (2-).
138. Weissberg D, Ben-Zeev I. Talc pleurodesis. Experience with 360 patients. J Thorac Cardiovasc Surg 1993;106:689-95. (2-).
139. Gasparri R, Leo F, Veronesi G, et al. Video-assisted management of malignant pleural effusion in breast carcinoma. Cancer 2006;106:271-6. (2-).
140. Qureshi RA, Collinson SL, Powell RJ, et al. Management of malignant pleural effusion associated with trapped lung syndrome. Asian Cardiovasc Thorac Ann 2008;16:120-3. (2-).
141. Colt HG. Therapeutic thoracoscopy. Clin Chest Med 1998;19:383-94. (4).
142. Cardillo G, Facciolo F, Carbone L, et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg 2002;21:302-6. (2+).
143. de Campos JR, Vargas FS, de Campos Werebe E, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest 2001;119:801-6. (2+).
144. PienGW, GantMJ,WashamCL, et al. Use of an implantable pleural catheter for trapped lung syndromein patients with malignant pleural effusion. Chest 2001;119:1641-6. (3).
145. Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000;69:369-75. (2+).
146. Warren W, Faber L. Clinical experience with Pleurx catheters for malignant pleural effusions. Chest 2000;118(Suppl):130S. (3).
147. Warren WH, Kalimi R, Khodadadian LM, et al. Management of malignant pleural effusions using the Pleur(x) catheter. Ann Thorac Surg 2008;85:1049-55. (2-).
148. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006;129:362-8. (2-).
149. Bertolaccini L, Zamprogna C, Barberis L, et al. Malignant pleural effusions: review of treatment and our experience. Rev Recent Clinical Trials 2007;2:21-5. (2-).
150. Janes SM, Rahman NM, Davies RJO, et al. Catheter-tract metastases associated with chronic indwelling pleural catheters. Chest 2007;131:1232-4. (3).
151. Martini N, Bains MS, Beattie EJ Jr. Indications for pleurectomy in malignant effusion. Cancer 1975;35:734-8. (3).
152. Fry WA, Khandekar JD. Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol 1995;2:160-4. (2-).
153. Bernard A, de Dompsure RB, Hagry O, et al. Early and late mortality after pleurodesis for malignant pleural effusion. Ann Thorac Surg 2002;74:213-17. (2-).
154. Waller DA, Morritt GN, Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest 1995;107:1454-6. (3).